Plus another 340B study shows a way the program can work to actually *help patients*
I said I'd be off, but didn't want to miss the chance to talk Pfizer, Madrigal and ... hockey hair
And Medicare coverage of weight-loss drugs is grabbing headlines following Wegovy's new approval
But there is also an IQVIA report that makes clear the cost of 340B to the average Joe
And why we should celebrate genericization
And I like BI's $35 inhaler pledge, even if I'm not tracking on the mechanics
And there is just an enormous pile of news to get through ...
And a must-read piece documenting the growth in access challenges in Part D
Plus a NYT guest essay that misses the point -- badly -- on where the obesity conversation needs to go
And some links from yesterday's Rare Disease Day hearing on the Hill
And Mr. Cuban goes to Washington
Plus some of the inside skinny on why Congress dropped PBM reform
